Novel Prognostic Markers in Renal Cancer: a Protocol for the Analysis of Paraffin Embedded Tumour Samples
Renal cancers have different clinical outcomes. The principal research objective is to study
tumour tissue from renal cancer patients and try and understand why some cancers progress
more rapidly than others. Further, another key aim of this study is to try and understand
why some patients respond to treatment and others do not.
Observational Model: Cohort, Time Perspective: Retrospective
The profiling of the expression of signal transduction biomarkers, gene expression, gene copy numbers and effect of mutations of the VHL gene in renal cancer and their relationship to clinical outcomes.
Professor Martin Gore
Royal Marsden NHS Foundation Trust
United Kingdom: Research Ethics Committee